NEUROCRINE BIOSCIENCES INC
10-Q, EX-27, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NEUROCRINE BIOSCIENCES INC, 10-Q, EX-10.5, 2000-08-11
Next: TRISM INC /DE/, 10-Q, 2000-08-11



<TABLE> <S> <C>

<ARTICLE>                                           5
<MULTIPLIER>                                        1,000

<S>                                                 <C>
<PERIOD-TYPE>                                       6-MOS
<FISCAL-YEAR-END>                                   Dec-31-2000
<PERIOD-START>                                      Jan-01-2000
<PERIOD-END>                                        Jun-30-2000
<CASH>                                                             2,472
<SECURITIES>                                                      77,346
<RECEIVABLES>                                                        869
<ALLOWANCES>                                                           0
<INVENTORY>                                                            0
<CURRENT-ASSETS>                                                  83,102
<PP&E>                                                                 0
<DEPRECIATION>                                                         0
<TOTAL-ASSETS>                                                    97,908
<CURRENT-LIABILITIES>                                              7,074
<BONDS>                                                                0
                                                  0
                                                            0
<COMMON>                                                              22
<OTHER-SE>                                                        86,831
<TOTAL-LIABILITY-AND-EQUITY>                                      97,908
<SALES>                                                                0
<TOTAL-REVENUES>                                                   5,720
<CGS>                                                                  0
<TOTAL-COSTS>                                                     20,326
<OTHER-EXPENSES>                                                      60
<LOSS-PROVISION>                                                       0
<INTEREST-EXPENSE>                                                    58
<INCOME-PRETAX>                                                  (11,039)
<INCOME-TAX>                                                         200
<INCOME-CONTINUING>                                                    0
<DISCONTINUED>                                                         0
<EXTRAORDINARY>                                                        0
<CHANGES>                                                              0
<NET-INCOME>                                                     (11,239)
<EPS-BASIC>                                                        (0.51)
<EPS-DILUTED>                                                      (0.51)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission